Target intelligence / Profile preview

TTC39A antisense RNA 1 (TTC39A-AS1)

Target
TTC39A-AS1
Molecular classification
Long non-coding RNA (lncRNA), Other
01

Overview

TTC39A antisense RNA 1 (TTC39A-AS1) is a human long non-coding RNA gene located on chromosome 1 (Ensembl: ENSG00000261664) with no protein-coding capacity[6][11][13]. TTC39A-AS1 is thought to regulate gene expression, including functioning as a competing endogenous RNA by sponging microRNAs—specifically, in breast cancer, it sponges miR-483-3p and upregulates MTA2, a metastasis-associated gene, thereby promoting tumorigenicity[3]. High levels of TTC39A-AS1 are correlated with worse prognosis in breast cancer. It is also associated with retinitis pigmentosa, although its precise role in this disease remains unclear[1]. Current evidence supports its role as a regulator of cellular processes such as apoptosis, proliferation, migration, and invasion, primarily through its interactions at the RNA level; it is not a conventional therapeutic target, such as a receptor or enzyme[2][3][4][5][6][13].

Other names
TTC39A-AS1Ttc39a opposite strand RNA 1Ttc39aos1lincRNA-EPSLOC102642299Gm12750
02

Biological functions

Regulation of gene expressionChromatin bindingRibonucleoprotein complex bindingTranscription cis-regulatory region bindingCompeting endogenous RNA function via microRNA interaction
03

Disease associations

Cancer (particularly breast cancer)Retinitis pigmentosa

Beyond the preview

Go deeper on TTC39A antisense RNA 1 (TTC39A-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TTC39A antisense RNA 1 (TTC39A-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call